Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 18,987 | 226,451 | 82,709 | 49,944 | 16,555 |
| Depreciation Amortization | 835 | 6,579 | 4,182 | 4,359 | 3,742 |
| Accounts receivable | -7,004 | -472 | 58 | -5,431 | 3,566 |
| Accounts payable and accrued liabilities | 1,903 | -1,351 | 1,538 | 2,339 | 1,789 |
| Other Working Capital | -10,879 | 4,155 | -26,152 | -30,646 | -5,968 |
| Other Operating Activity | 16,481 | -77,643 | 55,003 | 33,527 | 9,395 |
| Operating Cash Flow | $20,323 | $157,719 | $117,338 | $54,092 | $29,079 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -25,211 | -505,095 | -369,333 | -217,846 | -80,154 |
| PPE Investments | N/A | -523 | -70 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | 66,115 |
| Sale Of Investment | N/A | 328,565 | 216,715 | 147,615 | N/A |
| Purchase Sale Intangibles | -98,838 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -98,838 | 146,515 | 0 | 0 | 0 |
| Investing Cash Flow | $-124,049 | $-30,538 | $-152,688 | $-70,231 | $-14,039 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,838 | 6,845 | 4,876 | 4,608 | 1,043 |
| Financing Cash Flow | $1,838 | $6,845 | $4,876 | $4,608 | $1,043 |
| Exchange Rate Effect | -5 | -94 | -34 | 8 | 5 |
| Beginning Cash Position | 328,359 | 194,427 | 194,427 | 194,427 | 194,427 |
| End Cash Position | 226,466 | 328,359 | 163,919 | 182,904 | 210,515 |
| Net Cash Flow | $-101,893 | $133,932 | $-30,508 | $-11,523 | $16,088 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,323 | 157,719 | 117,338 | 54,092 | 29,079 |
| Capital Expenditure | N/A | -523 | -70 | N/A | N/A |
| Free Cash Flow | 20,323 | 157,196 | 117,268 | 54,092 | 29,079 |